OX40 (CD134) and OX40L
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-0-387-89520-8_6.pdf
Reference120 articles.
1. Paterson DJ, Jefferies WA, Green JR et al. Antigens of activated rat T lymphocytes inccluding a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol 1987; 24(12):1281–1290.
2. Mallett S, Fossum S, Barclay AN. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes—a molecule related to nerve growth factor receptor. EMBO J 1990; 9(4):1063–1068.
3. Baum PR, Gayle RB, 3rd, Ramsdell F et al. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp.34 EMBO J 1994; 13(17):3992–4001.
4. Baum PR, Gayle RBd, Ramsdell F et al. Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor. Circ Shock 1994; 44(1):30–34.
5. al_Shamkhani A, Birkeland ML, Puklavec M et al. OX40 is differentially expressed on activated rat and mouse T-cells and is the sole receptor for the OX40 ligand. Eur J Immunol 1996; 26(8):1695–1699.
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma;Radiation Oncology;2024-09-12
2. An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis;Cells;2024-03-28
3. Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy;Molecules;2024-01-17
4. ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype;Frontiers in Oncology;2023-08-18
5. Role of TNFSF9 bidirectional signal transduction in antitumor immunotherapy;European Journal of Pharmacology;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3